Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

ORGO

Organogenesis Holdings Inc.

CIK 0001661181 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$2.46
↓ 0.01 (-0.40%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Options; Risks: Fundamentals, Technicals

Key stats

Market Cap
$316.54M
P/E Ratio
116.42
EPS
0.16
Dividend Yield
Not covered
52W Position
8%
Beta
1.63

Valuation multiples

Fwd P/E
12.67
PEG
Not covered
P/B
1.29
P/S
0.62
EV/Revenue
0.44
ROE
1.1%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 8%
$2.04$7.08

Latest Financials

2025-12-31 FY
Revenue
$564.17M
Net Income
$37.03M
Total Assets
$598.73M
Free Cash Flow
-$24.46M

Recent news